As of 2018, more than 3,200 Emerging Biopharma (EBP) companies (characterized by R&D spend of less than $200 million or prescription sales up to $500 million) have an active R&D drug pipeline. Of the 8,700 products or programs in active development, ranging...
Account-based marketing. It’s all the rage. Most B2B commercial teams are at least thinking of implementing account-based marketing (ABM) programs if they haven’t already. But why is it a must-have for life science sales and marketing teams? What exactly is ABM? Our...
Amplion Lead Generation and Prospecting:A Guide for Life Science Sales and Marketing Teams FREE DOWNLOAD In this guide, you’ll learn ways to master: Want to upgrade your prospecting and lead gen processes for the better (and for good)? Establishing...
